AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials
Breakpoints
E-Petroboryl, A&2 Therapeutics
E-petroboryl, A&2 Therapeutics is a bioformaceutical company that actually uses a boron chemistry platform. This compound has a novel mechanism of action where an enzyme involved in protein synthesis called lucil tRNA synthetase is actually locked together to the terminal adenosine ribose of tRNA. In terms of in vitro activity, it has MICs demonstrated between 0.25 and 8. It has also excitingly demonstrated activity against chlorothermysin and ama casein resistant isolates.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode